PATIENT PREFERENCES: UNDERSTANDING RISK-BENEFIT TRADE-OFFS OF GENOMIC TESTING IN CHEMOTHERAPY DECISIONS FOR BREAST CANCER PATIENTS

被引：1
|
作者：
Marshall, D. [1 ,2 ]
Bombard, Y. [3 ]
Trudeau, M. [4 ]
Leighl, N. [5 ]
Pykerman, K. [6 ]
Deal, K. [7 ]
机构：
[1] Univ Calgary, Fac Med, Alberta Bone & Joint Hlth Inst, Calgary, AB, Canada
[2] Optuminsight, Calgary, AB, Canada
[3] Yale Univ, New Haven, CT USA
[4] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada
[5] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[6] Univ Calgary, Calgary, AB, Canada
[7] McMaster Univ, Hamilton, ON, Canada
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.724
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A147 / A148
页数：2
相关论文
共 50 条
  • [21] Thresholds of Benefit-Risk Trade-Offs from the Patient Perspective for Treatment Decisions in Moderate-to-Severe Rheumatoid Arthritis
    Husni, M. Elaine
    Griffith, Jenny
    Betts, Keith
    Song, Yan
    Ganguli, Arijit
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [22] Treatment of muscle invasive bladder cancer in the elderly: navigating the trade-offs of risk and benefit
    Noam A. VanderWalde
    Michelle T. Chi
    Arti Hurria
    Matthew D. Galsky
    Matthew E. Nielsen
    World Journal of Urology, 2016, 34 : 3 - 11
  • [23] Treatment of muscle invasive bladder cancer in the elderly: navigating the trade-offs of risk and benefit
    VanderWalde, Noam A.
    Chi, Michelle T.
    Hurria, Arti
    Galsky, Matthew D.
    Nielsen, Matthew E.
    WORLD JOURNAL OF UROLOGY, 2016, 34 (01) : 3 - 11
  • [24] Risk-benefit analysis of preoperative breast MRI in patients with primary breast cancer
    Siegmann, K. C.
    Baur, A.
    Vogel, U.
    Kraemer, B.
    Hahn, M.
    Claussen, C. D.
    CLINICAL RADIOLOGY, 2009, 64 (04) : 403 - 413
  • [25] Breast Cancer Patients' Views on the Use of Genomic Testing to Guide Decisions about Their Postoperative Chemotherapy
    Seror, V.
    Marino, P.
    Bertucci, F.
    Mancini, J.
    Extra, J. -M.
    Ferrero, J. -M.
    Bachelot, T.
    Viens, P.
    Julian-Reynier, C.
    PUBLIC HEALTH GENOMICS, 2013, 16 (03) : 110 - 117
  • [26] Patients', parents', and physicians' risk-benefit trade-off preferences for Crohn's disease treatments
    Johnson, F. R.
    Ozdemir, S.
    Mansfield, C.
    Hauber, A. B.
    Hass, S. L.
    Siegel, C. A.
    Sands, B. E.
    Miller, D. W.
    VALUE IN HEALTH, 2007, 10 (06) : A225 - A226
  • [27] Evaluation of psoriasis patients' attitudes toward benefit-risk and therapeutic trade-offs in their choice of treatments
    Eliasson, Lina
    Bewley, Anthony P.
    Mughal, Farhan
    Johnston, Karissa M.
    Kuznik, Andreas
    Patel, Chloe
    Lloyd, Andrew J.
    PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 353 - 362
  • [28] CAREGIVERS' STATED AND REVEALED PREFERENCES FOR ANTIPSYCHOTIC MEDICATION USE AMONG YOUTH: A DISCRETE CHOICE EXPERIMENT OF BENEFIT-RISK TRADE-OFFS
    Fu, Y. H.
    Amill-Rosario, A.
    Dosreis, S.
    VALUE IN HEALTH, 2024, 27 (06) : S9 - S10
  • [29] Trade-offs between overall survival and side effects in the treatment of metastatic breast cancer: eliciting preferences of patients with primary and metastatic breast cancer using a discrete choice experiment
    Bullen, Alistair
    Ryan, Mandy
    Ennis, Holly
    Gray, Ewan
    Loria-Rebolledo, Luis Enrique
    Mcintyre, Morag
    Hall, Peter
    BMJ OPEN, 2024, 14 (04):
  • [30] Patient evaluation of hormone therapy in breast cancer: Quantifying trade-offs between survival gains and quality of life
    Fellowes, D
    Fallowfield, L
    Saunders, C
    Houghton, J
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S122 - S122
12345